Brainscape's Knowledge GenomeTM

Browse over 1 million classes created by top students, professors, publishers, and experts.


See full index

Immunology > Week 8: Modern Antibody Therapy > Flashcards

Week 8: Modern Antibody Therapy Flashcards

1
Q

What is polyclonal antibodies?

A
  1. Bind to various epitopes on a specific antigen
  2. From many B cells
  3. Obtained from donation of blood products
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is monoclonal antibodies?

A
  1. Produced by one B cell clone
    2.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What is monoclonal antibodies?

A
  1. Produced by one B cell clone
  2. Bind to a specific epitope on a given antigen
  3. Same antigen binding site
  4. More expensive
  5. No batch to batch variability
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What secret polyclonal antibodies?

A

Multiple clones of antigen specific B cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

How is polyclonal antibodies derived?

A
  1. An experimental animal or human subject is immunized with Ag one or more times
  2. Subject is bled and Ab is purified from serum
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What are the pros of polyclonal?

A

A mixture of Ab directed toward a variety of epitopes are formed, good for agglutination and immunoprecipitation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What are the cons of polyclonal?

A
  1. May produce cross-reactivities against other Ag
  2. Different bleed points may yield different degrees of affinity
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What produces monoclonal antibodies?

A

Product of a single stimulated B cell

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What produces monoclonal antibodies?

A

Product of a single stimulated B cell

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

How is monoclonal antibodies derived?

A
  1. Fusion of B cells and immortalized myeloma cell
  2. Technique includes HAT selection medium for fused cells
  3. Produces mass quantities of single specificity Ab
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What is passable polyclonal antibodies?

A

Antibodies being passed from one host to another

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What is convalescent plasma CCP?

A
  1. Plasma is obtained from recovered individual by plasmapheresis
  2. Plasma is collected at 14 days past infection who meet strict criteria for donating blood
  3. Polyclonal antibodies neutralize pathogen
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What is plasmapheresis?

A

The process of separating plasma from whole blood components

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What does convalescent plasma CCP treat?

A
  1. H1N1 influenza
  2. 2003 SARS CoV 1
  3. 2012 MERS CoV
  4. COVID 19
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What is intravenous immunoglobin (IVIG) used for?

A
  1. Mostly IgG and varying IgA
  2. Provides passive immunity through the transfer of antibodies from one host to another
  3. Cna neutralize a wide range of antigens and superantigens
  4. Can provide immunoregulatory effects by suppressing functions of effector cells
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What are therapeutic proteins?

A
  1. Monoclonal antibodies
  2. ANtibodies
  3. Hormones
  4. Cytokines
  5. Enzymes
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

How are the characteristics monoclonal antibody production?

A
  1. mAb’s are large complex proteins
  2. Contain multiple disulfide bonds
  3. Glycosylated (post-translational modification)
  4. Require eukaryotic machinery to produce active form of protein
  5. Hybridoma technology was developed in 1975
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

How are monoclonal antibodies produced?

A
  1. Immunize animal with an antigen we want to target.
  2. Isolate B cells from the spleen of the immunized animal.
  3. Fuse immunized B cells with myeloma cells (tumor plasma cells) to form a hybridoma which will produce antibodies forever.
  4. Grow up the cells in a special media that will kill myeloma cells and B cells but will allow hybridoma cells to grow.
  5. A hybridoma will produce identical antibodies of a single specificity-monoclonal antibodies.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

What are the approaches of therapeutic antibody development?

A
  1. Mouse hydridoma
  2. Phage display
  3. Transgenic mouse
  4. Single B cell
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

What are the monoclonal antibody structures?

A
  1. Murine
  2. Chimeric
  3. Humanized
  4. Fully
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

What is murine mABs?

A

Fully derived from mice

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

What is chimeric mABs?

A

Murine variable region is spiced into the human constant region (70% human)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

What is humanized mAbs?

A

Murine hypervariable regions (CDRs) spliced into a human antibody (80-95% human)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

What is fully human mABs?

A

Completely derived from human sequence

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

What is the suffix -cept?

A

Fab portion has be replaced with a receptor protein sequence

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

What is guidance for industry?

A

FDS’s nonproprietary naming of biological products

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

How are biologics named?

A
  1. Monoclonal antibody core name
  2. Distinguishing, nonproprietary suffix
  3. Devoid of meaning
  4. 4 lowercase letters
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

What are the limiting factors of therapeutic antibodies?

A
  1. Immunogenicity
  2. Ability to reach the target tissue and with sufficient concentration
  3. Ability to trigger a particular biological effect that would modify a disease process
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

What is immunogenicity?

A

Ability of a substance to induce an immune response

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

What is immunogenicity good for?

A
  1. An infection but bad for therapeutic antibodies
  2. Leads to the production of anti drug antibodies (ADAs) that bind to and neutralize the therapeutic mAB thereby increasing clearance and decreasing efficacy
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

What are immunogenicity?

A

Contain epitopes that induce an immune response and are also targets of this immune resposne

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

What is reaching target tissue with sufficient concentration?

A
  1. Specificity for the target
  2. Antibody affintiy
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
33
Q

What is triggers biological effects that modify disease process?

A
  1. Blockade of factors that contribute to biological process
  2. Antibody mediated cell killing
34
Q

What is the structure of chimeric mAb?

A

4/12 domains are murine (2Vl and 2Vh)

35
Q

What is the structure of humanized mAb?

A

murine CDRs grafted into human mAb (IgG)

36
Q

What is the structure of fully humanized mAb?

A

the protein sequence is fully human

37
Q

What is the structure of pegylated Fab fragments?

A

polyethylene glycol is attached to the Fab portion of an IgG antibody

38
Q

What is the structure of receptor Fc fusion?

A

Functional receptor protein joined to the Fc portion of IgG

39
Q

What happens is the mAB is more humanized?

A

The less immunogenic

40
Q

What occurs when HAMA antibodies?

A

Increase clearance on mAb and cause hypersensitivity reactions

41
Q

What is pegylation?

A

Increases circulation retention, protect against enzymatic digestion, slows filtration by kidney, decreases generation of neutralizing antibodies

42
Q

What antibody isotope would make the best therapeutic?

A

IgG1

43
Q

What are the characterictics of IgG1?

A
  1. Structurally stable
  2. Long in vivo half-life
  3. Penetrate tissues
  4. Induce Fc mediated effector functions
44
Q

What sub isotopes are not desired by ADCC and CDC?

A

IgG2 and 4, Fab fragments

45
Q

What are the TNF-a inhibiors?

A
  1. Infliximab (Remicade)
  2. Certolizumab pegol (Cimzia)
  3. Etanercept (Enbrel
  4. Adalimumab (Humira)
46
Q

What is Adalimumab (Humira)?

A

Fully human (IgG1)

47
Q

What is Etanercept (Enbrel)?

A

(2) TNFR linked to IgG1 Fc

48
Q

What is Certolizumab pegol (Cimzia)?

A

Pegylated Fab’ fragment

49
Q

What is Infliximab (Remicade)?

A

Chimeric IgG1 mAb

50
Q

What are the functions of Fc independent ?

A

Neutralization/atagonism

51
Q

What are functions of Fc dependent?

A
  1. CDC
  2. ADCC
  3. Opsonization/Antibody Dependent Cellular Phagocytosis (ADCP)
52
Q

What are the targets of neutralization of mAbs?

A
  1. Receptors on the surface of cells
  2. Cytokines, growth factors secreted by cells
53
Q

What are the functions of anti-cytokine mAb?

A
  1. Bind to the cytokine preventing the cytokine from binding to its cytokine receptor and sending a signal
  2. Bind to cytokine receptor preventing cytokine from binding to the active site and sending a signal
54
Q

Why is mAb location important?

A

Determine how effective the antibody will be at preventing biological signaling

55
Q

What are the drugs that block HER2 through the ErbB receptor?

A

Trastuzumab (Herceptin) and Pertuzumab (Perjeta)

56
Q

What is Bamlanivimab (IgG1k) used for?

A

Against the spike protein of SARS-CoV-2 and blocks attachment to the human ACE2 receptor

57
Q

What is Etesevimab (IgG1k)

A

Against the spike protein of SARS-CoV-2 with amino acid substitutions in the Fc region to reduce effector function.

58
Q

What is the function of both Bamlanivimab and etesevimab?

A
  1. Bind to different but overlapping epitopes in the receptor binding domain (RBD) of the Spike protein.
  2. co-administered in approved individuals with mild to moderate COVID-19
  3. IV infusiotn
  4. Emergency use
59
Q

What is the use of mAb for COVID?

A

Neutralization by binding to SARS-CoV-2 preventing viral attachment and entry into cells

60
Q

How do we control T cell activation?

A

1.When targeting tumor cells, we want to increase T cell activation to cause cell death. Negative costimulatory proteins are blocked by mAbs to allow T cell activation.
2. In autoimmune conditions, we want to decrease T cell activation and this prevent inflammatory cytokine production.

61
Q

What is the overview of antibody mediated effector mechanisms?

A
  1. All effectors of the mechanisms require the presence of the Fc portion of the antibody
  2. Therapeutics contains only the Fab portion may block signaling without inducing these mechanism
62
Q

What are the mechanisms for cell death?

A
  1. CDC
  2. ADCC
  3. ADCP
63
Q

What is CDC?

A
  1. Fc region of mAb can recruit effector cells such as NK cells, macrophages or neutrophils to activate complement mediated cell death by cell lysis
  2. Activation of complement causes release of C3a, C4a, and C5a and cause inflammation
64
Q

What is ADCC?

A
  1. Fc region of mAb can recruit effector cells such as NK cells.
  2. NK cells form an immunological synapse with antibody labeled target cell.
  3. NK cells release granular contents to induce apoptosis.
  4. Apoptosis is a less inflammatory form of cell death.
65
Q

What is ADCP?

A
  1. Fc receptor dependent form of cell death.
  2. Macrophages and neutrophils have FcRs that recognize the Fc portion of the IgG mAb.
  3. This triggers the phagocytosis of the antibody coated target cell.
  4. Referred to as ADCP when it is a tumor cell or altered host cell instead of opsonization.
66
Q

What are biosimilars?

A

Same aa sequence as original mAb bu produced from a different clone and can have different glycosylations

67
Q

What are the modifications of biosimilars?

A
  1. Improve binding affinity (CDR regions)
  2. Reduce immunogenicity
  3. Influence the Fc mediated effector functions
68
Q

What are the side effects of monoclonal Ab?

A
  1. Risk of immune reactions
  2. Acute anaphylaxis (infusion reaction, IgE mediated)
  3. Serum sickness
  4. Generation of anti drug antibodies
  5. Acute infusion reactions
  6. Risk of infection and malignancy
69
Q

How can mAb thrapy cause immune reactions?

A
  1. Due to immunogenicity of mAB
  2. More prevalent with murine mAb
70
Q

How can mAb therapy cause serum sickness?

A

More common in chimeric mAb

71
Q

How can mAb therapy cause generation of anti drug antibodies?

A
  1. All mAbs will cause the generation of anti-drug antibodies with repeated administration.
  2. Anti-drug antibodies are more common with more immunogenic mAbs
72
Q

How can mAb therapy cause risk of infection and malignancy?

A
  1. mAbs against TNFα have been associated with reactivation of latent tuberculosis, as well as with other serious infections and malignancies.
  2. Development of an acquired immunodeficiency
73
Q

What is Enzyme-linked immunosorbent assay (ELISA)?

A

Assays that use antibodies or antigens covalently bound to enzymes

74
Q

What is indirect ELISA?

A
  1. Detects presence and concentration of Ab in a sample
  2. Method of choice to detect presence of serum Ab against HIV, HBV, HCV
75
Q

What is sandwich ELISA?

A
  1. Measures Ag presence and levels
  2. Useful for measurement of soluble cytokine concentrations
76
Q

What is competitive ELISA?

A
  1. Measures amount of Ag in a sample
  2. The more Ag in original sample, the lower the final signal
77
Q

What is Lateral Flow Immunoassay used for?

A

Used to detect presence of antigen or antibody in clinical sample

78
Q

What are analyses?

A

urine, saliva, sweat, serum, plasma, blood, mucous

79
Q

How is lateral flow immunoassay

A
  1. Liquid sample is placed on absorbent pad and carried by flow of buffer added to pad.
  2. Sample interacts with antibodies that are specific for the target analyte and are conjugated to colored particles–most commonly colloidal gold
  3. Test line contains mAbs to analyte
  4. Control line contains mAb to species of mAb-colloidal gold or to colloidal gold
80
Q

What is hemagglutination?

A

Used to detect any Ag conjugated to the surface of RBCs

81
Q

What occurs during an agglutination reaction?

A
  1. Antibodies that can bind a surface Ag will cross-link the RBCs, forming a large clump that doesn’t settle in the plate or test tube
  2. Routinely used in blood typing- Coombs Test
  3. Can be adapted to measure levels of Ab in a sample directed against any Ag that can be attached to the surface of an RBC

Immunology (17 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2024 Bold Learning Solutions. Terms and Conditions